Digital Technology in Clinical Trials

In today’s technology enabled world, it seems like every time we turn around, there is another cyber-attack or penetration of computing environment that render sensitive data subject to malicious use. These incidents are broadly portrayed around the world and, as a result, have made organizations, patients involved in clinical trials and others involved in clinical research reticent to use new and burgeoning technologies in the conduct of clinical trials. In addition, global regulators and ministries of health have enacted exacting data privacy regulations and guidance that are aimed at ensuring patients’ rights and desires are carried out in the use of their data. This current situation should not stymie innovation and the use of new technologies but rather should cause us to rise up and ensure that our vendors and technologies are architected in a way to withstand attacks and put into place policies and measures that will ensure the privacy of data. This session is aimed at providing participants with information that they can use to effect change within their own organizations and to put into place controls to ensure the privacy of data.